Omnia molecular

Omnia Molecular was devoted to the design and development of anti-infectives targeted at difficult-to-treat infections. Lead compounds were synthesized and optimized using a proprietary technology platform and proved effective in several biological assays.
It has suspended its activities in 2016.

Image: